Collegium Pharmaceutical
COLL
24.72
-0.49
-1.94%
Collegium Pharmaceutical
US · COLL
#3535 by market cap
Listed 2015
24.72
-0.49
-1.94%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Collegium Pharmaceutical
Collegium Pharmaceutical, Inc. is a dynamic, biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions. The firm has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.
- Founded
- 2002
- CEO
- Mr. Vikram Karnani
- Employees
- 423
- Headquarters
- Stoughton, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- collegiumpharma.com
Company profile
- Exchange
- US
- Symbol
- COLL
- Market-cap rank
- #3535
- Listing date
- 2015-05-07
- Market cap
- 768.18M
- Float cap
- 698.96M
- Shares out
- 31.08M
- Float shares
- 28.27M
Sectors & themes
Best Growth Stocks
Drug Manufacturers - Specialty & Generic
Fractional Shares JP
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Collegium Pharmaceutical discussion 0 comments